EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance

Merel Oeyen iD, Clément J F Heymann iD, Maarten Jacquemyn iD, Dirk Daelemans iD, Dominique Schols iD

Biosensors · 2024

DOI: 10.3390/bios14080362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2024. Verfasst von Merel Oeyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, …. Hauptthemen laut MEDLINE: Zika Virus, Hepatitis A Virus Cellular Receptor 1, Zika Virus Infection, Virus Internalization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Laboratory of Virology and Chemotherapy (Rega Institute, KU Leuven).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthoflaviviruses cause a major threat to global public health, and no antiviral treatment is available yet. Zika virus (ZIKV) entry, together with many other viruses, is known to be enhanced by phosphatidylserine (PS) receptors such as T-cell immunoglobulin mucin domain protein 1 (TIM-1). In this study, we demonstrate for the first time, using cell-based electrical impedance (CEI) biosensing, that ZIKV entry is also enhanced by expression of CD300a, another PS receptor. Furthermore, inhibiting CD300a in immature monocyte-derived dendritic cells partially but significantly inhibits ZIKV replication. As we have previously demonstrated that CEI is a useful tool to study Orthoflavivirus infection in real time, we now use this technology to determine how these PS receptors influence the kinetics of in vitro ZIKV infection. Results show that ZIKV entry is highly sensitive to minor changes in TIM-1 expression, both after overexpression of TIM-1 in infection-resistant HEK293T cells, as well as after partial knockout of TIM-1 in susceptible A549 cells. These results are confirmed by quantification of viral copy number and viral infectivity, demonstrating that CEI is highly suited to study and compare virus-host interactions. Overall, the results presented here demonstrate the potential of targeting this universal viral entry pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika VirusHepatitis A Virus Cellular Receptor 1Zika Virus InfectionVirus InternalizationElectric ImpedanceHumansHEK293 CellsA549 CellsReceptors, ImmunologicVirus ReplicationBiosensing TechniquesSialic Acid Binding Ig-like Lectin 1

Stichwörter der Autor:innen

CD300aTIM-1impedancephosphatidylserine receptorzika virus

Substanzen

Hepatitis A Virus Cellular Receptor 1HAVCR1 protein, humanReceptors, ImmunologicSIGLEC1 protein, humanSialic Acid Binding Ig-like Lectin 1

Autor:innen und Institutionen

  • Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.

ORCID-Profile: Merel Oeyen, Clément J F Heymann, Maarten Jacquemyn, Dirk Daelemans, Dominique Schols

Förderung

  • Laboratory of Virology and Chemotherapy (Rega Institute, KU Leuven)

Zitieren

APA

Oeyen, M., Heymann, C. J. F., Jacquemyn, M., Daelemans, D., & Schols, D. (2024). The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance. Biosensors. https://doi.org/10.3390/bios14080362

Vancouver

Oeyen M, Heymann CJF, Jacquemyn M, Daelemans D, Schols D. The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance. Biosensors. 2024. doi:10.3390/bios14080362

BibTeX
@article{Oeyen2024,
  author = {Oeyen, Merel and Heymann, Clément J F and Jacquemyn, Maarten and Daelemans, Dirk and Schols, Dominique},
  title = {The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance},
  journal = {Biosensors},
  year = {2024},
  doi = {10.3390/bios14080362}
}
Kostenlos starten →